Incidence and potential predictors of SGLT2 inhibitor initiation in acutely hospitalized patients with heart failure
Use of SGLT2 inhibitors remains low despite recommendations advocating for their use in heart failure, with these agents specifically underutilized in HFpEF and HFmrEF at this institution.
Authors
- Jessica C. Brumit (ORCID: https://orcid.org/0000-0002-5138-0475)
- Jennifer L. Tharp
- Kelly Covert (ORCID: https://orcid.org/0000-0003-1262-9423)
- Jacquelyn Crawford (ORCID: https://orcid.org/0009-0006-9496-942X)
- Cameron Lanier (ORCID: https://orcid.org/0009-0009-8098-0240)
- V. K. Wilson
- Kathleen M. White
Institutions
- East Tennessee State University (US)
- Johnson City Medical Center (US)
- Ballad Health (US)
Publication Details
- Journal
- American Journal of Health-System Pharmacy
- Published
- 2025-02-06
- DOI
- https://doi.org/10.1093/ajhp/zxaf025
- Citations
- 3
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 3.88